Advertisement
Advertisement
U.S. markets open in 44 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Pulse Biosciences, Inc. (PLSE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9300-0.0100 (-0.52%)
At close: 04:00PM EDT
Advertisement
Sign in to post a message.
  • D
    Dick
    :
    Less than a year ago, on August 11, one day after DPH approved CellFX for treatment of non cancerous lesions, stock traded at 26.50 on volume of 2,305,600 of 2,305,600. How high will it jump when DPH approves treatment of basal cell carcinoma ?
  • M
    Mike
    20 lesions treated in one day in one clinic. Facebook knows?
  • T
    Truth
    Go Up
    Bullish
  • b
    brian
    When will offering be complete and shares and warrants distributed
  • G
    GE
    Hope is the last
    thing ever lost. (HE KNOWS)!!!
    Bullish
  • Z
    Zooiiiogloo2MabModTilSo
    @ GE.. MM cash budget $15m + $12.6m => $27.6m balance sheet...
    * the numbers didn't lie....
  • C
    Chari
    Average price used for the offering should be roughly around $2.09. This is just back of the envelope calculation. Obviously the high volume of trade on 5/16 weighs heavily on the average.
  • S
    Steve
    Unfortunately the companies sales & marketing execution is to blame here! The tech works and is the best solution to remove skin lesions, and once the basal cancer is approved that is the game changer! No more Mohs barbaric surgery! They need to hold on and fix the sales / marketing execution problem. They are to engineering focused and don’t understand that now that they have a product you need a marketing and sales plan and much better market messaging on the benefits of this new process vs all current “bad” processes. Net net patents and technology is solid! Way under valued.
  • B
    Bob
    They just extended the rights offering by three days to May 26th so as to give substantial time to shareholders after todays annual shareholders meeting. Maybe they think this meeting will impact share price?
  • H
    HJ_BufGra
    💵PLSE is short sale restricted for 2022-05-13.💣Consider 💰PED (pedevco) low float oil stock. ER Today 100~300% ⬆️📈
    Bullish
  • B
    Bob
    I got out around $4.20 - after substantial loss. I kept small number of shares for this rights offering. Just called it in and oversubscribed.

    We could easily be in for more pain here - they ain’t raising a lot of money with this raise and will definitely need more.

    But I think the tech is pretty special so I’m willing to ride out these massive bumps.
  • B
    Bob
    The rights offering was oversubscribed. That’s good news.
  • L
    Lamhobe
    My example of the stock price hitting $1 for the rights offering was meant to be extreme not a prediction! The offering will be canceled, I bet, unless Duggan does massive oversubscription. He just loaned SMMT $25 million, so that might happen here too.
  • G
    GE
    Patience is not the ability to wait, but the ability to keep a good attitude while waiting.” …………………(HE KNOWS)!!!
    Bullish
  • G
    GE
    Mr. Duggan will be loading up like there’s no tomorrow!!! (HE KNOWS). Never felt more confident go forward!!!
    Bullish
  • J
    Jerry
    Why should I use the rights offering? Now the stock price is way lower than $3.72. They said the extra money will be used to give me more shares, but what is the advantage over buying the shares directly in the market?
  • L
    Lamhobe
    To give an example of the dilution at a low share price - and how Duggan could pick up a huge share of this company if the stock price is low - I’ll do my best to present an accurate numerical example.

    Each share entitles you to approximately 0.1353 units in the rights offering if it takes place at $3.72, if you participate, you’ll own 1.1353 shares after and own the same percentage of the company. If you do not, you’ll have 1 share, but you’ll own 0.1353/1.1353 less of the company, or about 12%. You’d also miss the warrants. If they were worth exercising, your ownership percentage would decrease by 0.2706/1.2706 or about 21%.

    Let’s take an extreme case (I hope!) that the stock price is such that the offering takes place at $1. Then each share will entitle you to 0.372 units. Not participating will reduce the ownership stake by 0.372/1.372 or approximately 27%. But it can get worse with the warrants. If you do not participate, then your ownership percentage decreases 0.744/1.744 or about 43%.

    I’m lazy, but I think the corresponding numbers at $2.50 are 18% and 31%.

    Realize that if Duggan exercises his oversubscription rights, he gets at least 50.5% of what you lose.
  • J
    Jerry
    The company hopes its stock price is higher this week because the average price over this week is used as a factor in determining the rights offering price.
  • D
    Dick
    Duggan is on a mission and has given us loyal shareholders a seat on the wagon. Don't try to analyse it - Sit back and enjoy it
    Bullish
  • L
    Lamhobe
    I’m not sure what to make of this. Bob seems lukewarm. Or maybe that’s what he wants us to think to gobble more of our rightful shares. I am exercising all of my basic subscription rights but no oversubscription. The risk of substantial dilution of the stock price remains significantly below $3.72 is too high, especially given the warrants.

    From the prospectus:

    “Robert W. Duggan, the beneficial owner of approximately 50.5% of our outstanding common stock as of the Record Date, has indicated that he intends to exercise all of his basic subscription rights, but he has not made any formal binding commitment to do so. Mr. Duggan also reserves the right to exercise any over-subscription rights to purchase additional Units that remain unsubscribed at the expiration of the rights offering, subject to availability, but he has not made a decision with respect to such over-subscription at this time. If other stockholders do not exercise their subscription rights and Mr. Duggan exercises all of his basic subscription rights, but only his basic subscription rights, then Mr. Duggan would become the beneficial owner of approximately 53.63% of our common stock, assuming no exercise of the warrants to purchase shares of common stock acquired in this offering. However, if none of our other stockholders exercise their subscription rights and Mr. Duggan exercises, at the Initial Price, all of his basic subscription rights, all of his over-subscription rights, and all of the warrants being offered in the rights offering, then he would become the beneficial owner of approximately 61.01% of our common stock. Mr. Duggan’s beneficial ownership following the completion of the rights offering, assuming no other stockholders subscribe for Units and Mr. Duggan exercises all of his basic subscription rights, all of his over-subscription rights, and all of the warrants, is calculated by adding 15,038,580, which is the number of shares Mr. Duggan owned as of the Record Date, to 8,064,516, which is the approximate number of shares we expect to issue as a result of this rights offering assuming (i) no additional shares of common stock are issued by us prior to consummation of the rights offering, (ii) all offered Units (which consist of shares of common stocks and warrants) are sold in the rights offering at the Initial Price, and (iii) all of the warrants issued in the rights offering are exercised. Percentages are calculated based on 29,802,280 shares of common stock outstanding as of the Record Date.”
Advertisement
Advertisement